Cargando…

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions

Several key advances in the treatment of B-cell non-Hodgkin lymphoma (B-NHL) over the past two decades have strategically exploited B-cell lineage markers suitable for targeting by immunotherapies. First, the addition of the anti-CD20 monoclonal antibody (mAb) rituximab to a range of standard therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russler-Germain, David A., Ghobadi, Armin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351267/ https://www.ncbi.nlm.nih.gov/pubmed/37465110 http://dx.doi.org/10.3389/fonc.2023.1168622

Ejemplares similares

Radioimmunotherapy of B-Cell Non-Hodgkin’s Lymphoma
por: Bodet-Milin, Caroline, et al.
Publicado: (2013)

T-cell Redirecting Therapies for the Treatment of B-cell Lymphomas: Recent Advances
por: Messéant, Ondine, et al.
Publicado: (2021)

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas
por: Crisci, Stefania, et al.
Publicado: (2019)

Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies
por: Ricci, Jean-Ehrland, et al.
Publicado: (2018)

Diagnosis and management of AL amyloidosis due to B-cell non-Hodgkin lymphoma
por: Berkowitz, Callie, et al.
Publicado: (2022)

Determinants of Drug Resistance in B-Cell Non-Hodgkin Lymphomas: The Case of Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia
por: Piazza, Francesco, et al.
Publicado: (2022)

Advances in the treatment of Hodgkin lymphoma: Current and future approaches
por: Ullah, Fauzia, et al.
Publicado: (2023)

Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas
por: Witte, Hanno Maximilian, et al.
Publicado: (2023)

Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?
por: Ribatti, D, et al.
Publicado: (1998)

Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin’s lymphoma
por: Song, Jiwei, et al.
Publicado: (2022)

Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions
por: Chen, Huan, et al.
Publicado: (2021)

Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
por: Ali, Aesha I., et al.
Publicado: (2019)

Primary diffuse large B-cell non-Hodgkin's lymphoma of the breast—A case report and review of the literature
por: Harb, Ola A., et al.
Publicado: (2018)

CAR T-Cell Therapy for B-Cell non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia: Clinical Trials and Real-World Experiences
por: Vitale, Candida, et al.
Publicado: (2020)

Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy
por: Vercellino, Laetitia, et al.
Publicado: (2021)

Genetically Determined Height and Risk of Non-hodgkin Lymphoma
por: Moore, Amy, et al.
Publicado: (2020)

Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma
por: Lv, Liwei, et al.
Publicado: (2021)

Non-Hodgkin’s Lymphoma: An Unusual Cause of Shoulder Pain
por: Yeak, Raymond D.K., et al.
Publicado: (2023)

Recent Advances in the Targeting of Epigenetic Regulators in B-Cell Non-Hodgkin Lymphoma
por: Ribeiro, Marcelo L., et al.
Publicado: (2019)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
por: Chavez, Julio C., et al.
Publicado: (2022)

Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma
por: Panayi, Christos, et al.
Publicado: (2023)

A Prospective Investigation of Bispecific CD19/22 CAR T Cell Therapy in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
por: Zhang, Ying, et al.
Publicado: (2021)

Expression and Regulation of the Endogenous Retrovirus 3 in Hodgkin’s Lymphoma Cells
por: Kewitz, Stefanie, et al.
Publicado: (2013)

Retroperitoneal extra-adrenal non-Hodgkin lymphoma: An uncommon presentation
por: Ayari, Y., et al.
Publicado: (2018)

Modeling Gene-Environment Interaction for the Risk of Non-hodgkin Lymphoma
por: Zhang, Jiahui, et al.
Publicado: (2019)

Yescarta: A New Era for Non-Hodgkin Lymphoma Patients
por: AlDallal, Salma M
Publicado: (2020)

The role of transplantation in Hodgkin lymphoma
por: Maranzano, Michael, et al.
Publicado: (2023)

Meningeal Relapse of Nodular Lymphocyte Predominant Hodgkin Lymphoma Transformed to T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Case Report
por: Salvioni Chiabotti, Paolo, et al.
Publicado: (2020)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Anti-CD19 Chimeric Antigen Receptor T Cells in Combination With Nivolumab Are Safe and Effective Against Relapsed/Refractory B-Cell Non-hodgkin Lymphoma
por: Cao, Yaqing, et al.
Publicado: (2019)

Inflammatory microenvironment in classical Hodgkin’s lymphoma with special stress on mast cells
por: Ribatti, Domenico, et al.
Publicado: (2022)

Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma
por: Tamayo-Orbegozo, Estíbaliz, et al.
Publicado: (2020)

HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies
por: Cao, Xing, et al.
Publicado: (2021)

Radiotherapy for Non-Hodgkin’s lymphoma with cardiac infiltration: A case report
por: Wang, Weifeng, et al.
Publicado: (2023)

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
por: Khan, Muhammad Rahil, et al.
Publicado: (2018)

Relapsed Mantle Cell Lymphoma: Current Management, Recent Progress, and Future Directions
por: Bond, David A, et al.
Publicado: (2021)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Outcomes of Diffuse Large B-Cell Non-Hodgkin’s Lymphoma After Gemcitabine-Based Second Salvage Chemotherapy: A Single-Center Study
por: Jhatial, Mussadique Ali, et al.
Publicado: (2021)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
por: Cellini, Alessandro, et al.
Publicado: (2023)

T‐cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions
por: O'Neill, Chloe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dka2k35hofdebs9iiijck72v1a